AGREEMENT AND PLAN OF MERGER AMONG XOMA ROYALTY CORPORATION XRA 3 CORP. AND TURNSTONE BIOLOGICS CORP. DATED AS OF JUNE 26, 2025Agreement and Plan of Merger • July 1st, 2025 • Turnstone Biologics Corp. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 1st, 2025 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of June 26, 2025 (this “Agreement” and, such date, the “Agreement Date”), by and among XOMA Royalty Corporation, a Nevada corporation (“Parent”), XRA 3 Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Turnstone Biologics Corp., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER AMONG XOMA ROYALTY CORPORATION XRA 3 CORP. AND TURNSTONE BIOLOGICS CORP. DATED AS OF JUNE 26, 2025Agreement and Plan of Merger • June 27th, 2025 • Turnstone Biologics Corp. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 27th, 2025 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of June 26, 2025 (this “Agreement” and, such date, the “Agreement Date”), by and among XOMA Royalty Corporation, a Nevada corporation (“Parent”), XRA 3 Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Turnstone Biologics Corp., a Delaware corporation (the “Company”).